Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

Healthcare Biotechnology
ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Asep Medical Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
  • SkywalkerofLukeX
Post by SkywalkerofLukeon Jun 14, 2022 4:41pm
176 Views
Post# 34756312

Recent News

Recent News

$ASEP.c $SEPSF announced yesterday that they’ve received official allowance of its patent claims for their first-generation sepsis diagnostic technology (in the EU).


COO of $ASEP mentioned that “This opens up huge markets where our diagnostic test will have the benefit of exclusivity due to patent protection” and can eventually become commercialized once it receives regulatory approval.


Sepsis occurs in 49M ppl worldwide and the current diagnostic tech takes 24-48 hrs. $ASEP ‘s tech diagnoses severe cases within 1-2 hrs and with approved patents in the EU this a big step in getting their tech out there.


https://www.newswire.ca/news-releases/asep-medical-inc-announces-allowance-of-european-patent-for-first-generation-sepsis-diagnostic-technology-sepseter--826500872.html

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities